Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × TP53 × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 7 Myelodysplastic Syndromes 2 TP53 1 Primary Malignant Neoplasm of Ovary 1 Older Patients 1 Hodgkin Disease 1 GATA2 Deficiency 1 Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Decitabine 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04123392 2019-10-10

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown

TP53

Data powered by HemOnc (CC BY 4.0) Colophon ⚡